OABI.NASDAQOmniab, INC

Form 4: OmniAb Director Steven Love Reports Stock Transactions

Sentiment:

Insider Transaction Report


OmniAb, Inc. Director Steven Love reported transactions involving common stock, restricted stock units, and stock options on June 17, 2026.

Summary

  • Director Steven Love of OmniAb, Inc. (OABI) reported several transactions on June 17, 2026.
  • These transactions include the vesting of 20,000 Restricted Stock Units (RSUs) and the acquisition of 40,000 stock options.
  • Following these events, Mr. Love beneficially owns 91,666 shares of common stock directly.
  • The RSUs vest on the earlier of the next annual meeting or the first anniversary of the grant date.
  • Stock options become exercisable on the earlier of the next annual meeting or the first anniversary of the grant date, with an exercise price of $2.03 and an expiration date of June 17, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider equity transactions rather than significant strategic or financial performance indicators.

Positives

  • Director Steven Love's beneficial ownership of OmniAb common stock remains significant at 91,666 shares after reported transactions.
  • The acquisition of 40,000 stock options indicates continued incentive alignment with the company's performance.
  • The vesting of 20,000 RSUs suggests progress towards fulfilling equity-based compensation plans.

Future Outlook

The vesting and exercisability of RSUs and stock options are tied to specific future dates, namely the next annual stockholder meeting or the first anniversary of the grant date, indicating a structured approach to equity compensation realization.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. This filing by an OmniAb director is typical for executive compensation and ownership reporting within the biotechnology sector.

Stakeholder Impact

  • Shareholders: Increased transparency into director's equity holdings and potential future share sales or acquisitions.
  • Employees: Reinforces the company's use of equity-based compensation as a retention and incentive tool.

Next Steps

  • The RSUs will vest on the earlier of the next annual meeting of stockholders or the first anniversary of the grant date.
  • The stock options will become exercisable on the earlier of the next annual meeting of stockholders or the first anniversary of the grant date.

Key Dates

DateDescription
06/17/2025Grant date for RSUs and Stock Options
06/17/2026Date of earliest transaction reported; vesting of RSUs and acquisition of stock options.
06/17/2036Expiration date for stock options.
06/18/2026Date the Form 4 was signed by the attorney-in-fact.

Keywords

OmniAb, OABI, Form 4, SEC Filing, Stock Options, Restricted Stock Units, Insider Trading, Beneficial Ownership, Director Transactions

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.